Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Can Lin

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Hepatology International|June 29, 2023
Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patientsKong-Ying Lin, Zhi-Wen Lin, Qing-Jing Chen, et al.
Frontiers in Immunology|March 4, 2024
Serum alpha-fetoprotein response as a preoperative prognostic indicator in unresectable hepatocellular carcinoma with salvage hepatectomy following conversion therapy: a multicenter retrospective studyKong-Ying Lin, Jian-Xi Zhang, Zhi-Wen Lin, et al.
International Immunopharmacology|November 5, 2023
Association of hepatitis B virus DNA levels with efficacy and safety outcomes in patients with hepatitis B virus-associated advanced hepatocellular carcinoma receiving tyrosine kinase inhibitor plus anti-PD-1 antibody: a multicenter propensity-matched studyQing-Jing Chen, Kong-Ying Lin, Zhi-Wen Lin, et al.
BMC Cancer|December 5, 2023
Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of 2770 patientsKong-Ying Lin, Qing-Jing Chen, Shi-Chuan Tang, et al.
Digestive Surgery|September 11, 2025
Association between Textbook Outcomes of Liver Surgery and Overall Survival in Gallbladder Cancer Patients Treated with Curative-Intent Resection: A Multicenter StudyZi-Mu Li, Hui-Ying Ouyang, Yi Gong, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Hepatology International|June 29, 2023
Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patientsKong-Ying Lin, Zhi-Wen Lin, Qing-Jing Chen, et al.
Frontiers in Immunology|March 4, 2024
Serum alpha-fetoprotein response as a preoperative prognostic indicator in unresectable hepatocellular carcinoma with salvage hepatectomy following conversion therapy: a multicenter retrospective studyKong-Ying Lin, Jian-Xi Zhang, Zhi-Wen Lin, et al.
International Immunopharmacology|November 5, 2023
Association of hepatitis B virus DNA levels with efficacy and safety outcomes in patients with hepatitis B virus-associated advanced hepatocellular carcinoma receiving tyrosine kinase inhibitor plus anti-PD-1 antibody: a multicenter propensity-matched studyQing-Jing Chen, Kong-Ying Lin, Zhi-Wen Lin, et al.
BMC Cancer|December 5, 2023
Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of 2770 patientsKong-Ying Lin, Qing-Jing Chen, Shi-Chuan Tang, et al.
Digestive Surgery|September 11, 2025
Association between Textbook Outcomes of Liver Surgery and Overall Survival in Gallbladder Cancer Patients Treated with Curative-Intent Resection: A Multicenter StudyZi-Mu Li, Hui-Ying Ouyang, Yi Gong, et al.
Pageof 7